The $13.4 million PENNDOT construction project to realign Langley Avenue is continuing as planned. With the spring season in full swing, the realignment of Langley Avenue has entered into its final stages of reconstruction. The final phase will impact the City of Philadelphia-owned stretch of Broad Street just north of the Navy Yard gates.
Ameresco, Inc., a leading energy efficiency and renewable energy company, and PIDC, Philadelphia’s public-private economic development corporation and master developer of the Navy Yard, today announced the final completion of the six megawatt (6 MW) natural gas-fired peaking plant at the Navy Yard in Philadelphia, and that the plant is now operational. Earlier today, representatives
In March 2017, Jefferson Health, Liberty Property Trust, and Synterra Partners announced plans for expanded services offered by Jefferson at the Navy Yard, by leasing additional space to open a 70,000-plus square-foot facility at Three Crescent Drive by early to mid-2018. Jefferson’s vision for the Navy Yard is to create a consumer-oriented healthcare destination located
PIDC, Philadelphia’s public-private economic development corporation, today announced the start of construction on the first phase of a community-shared solar power project at the Navy Yard. The initial installation includes 1,295 solar panels on a rooftop in the Navy Yard and will provide a total of 440kW system capacity for the district. The Navy Yard
Excited to be a part of the exciting growth of the Philadelphia Navy Yard, the Courtyard Philadelphia South announces the completed expansion with a new neighboring building providing an additional 42 guest rooms. The addition will accommodate the visitor demand of the Navy Yard and Philadelphia’s major sports venues. Already the recipient of the TripAdvisor
Jefferson Health will offer expanded services at the Navy Yard, having signed a multi-year lease agreement with Liberty Property/Synterra, a joint venture of Liberty Property Trust and Synterra Partners, for additional space to open a 70,000-plus square-foot facility at 3 Crescent Drive by early to mid-2018.
Adaptimmune Therapeutics plc. (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced it will host a ribbon cutting ceremony this morning at 10:30am at the Navy Yard in Philadelphia to celebrate the opening of its newly constructed U.S. headquarters and base for clinical and manufacturing operations. Developed by Liberty Property Trust (NYSE:
Liberty Property Trust and PIDC joined WuXi AppTec, Inc., a global leader in pharmaceuticals, biopharmaceuticals, and medical devices, for a ribbon cutting ceremony to open their third facility at the Navy Yard. This new 150,000 square foot facility which, when fully operational, has the potential to accommodate an additional 200 high tech manufacturing and support
PIDC, Philadelphia’s public-private economic development corporation, announced that The Navy Yard experienced another tremendous year of growth in 2015, adding 12 new businesses and over 500 additional employees, bringing the total counts to 152 companies and 12,000 workers.
Adaptimmune Therapeutics plc. (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced plans to locate its U.S. headquarters and clinical operations in a newly developed facility to be constructed at The Navy Yard in Philadelphia. The 47,400 square foot facility, located at 351 Rouse